These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26699699)

  • 1. Are Myeloproliferative neoplasms a risk factor for Heparin-Induced Thrombocytopenia?
    Bovet J; De Maistre E; Bejot Y; Girodon F
    Br J Haematol; 2016 Nov; 175(3):537-539. PubMed ID: 26699699
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acquired thrombophilic disorders in 2011: focus on heparin-induced thrombocytopenia, antiphospholipid syndrome, myeloproliferative neoplasms and paroxysmal nocturnal hemoglobinuria.
    Emadi A; Streiff M
    Arch Iran Med; 2011 Nov; 14(6):401-11. PubMed ID: 22039845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-Induced thrombocytopenia (HIT): a case study.
    Newkirk CE
    Clin Lab Sci; 2010; 23(1):5-11. PubMed ID: 20218089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection increases the risk of heparin-induced thrombocytopenia.
    Thompson GR; Lawrence VA; Crawford GE
    Clin Infect Dis; 2007 Nov; 45(10):1393-6. PubMed ID: 17968841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia: evaluation of IgG and IgGAM ELISA assays.
    Morel-Kopp MC; Aboud M; Tan CW; Kulathilake C; Ward C
    Int J Lab Hematol; 2011 Jun; 33(3):245-50. PubMed ID: 21118381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin induced thrombocytopenia: a life and limb threatening complication of heparin therapy.
    Kapsch DN; Silver D
    Mo Med; 1979 May; 76(5):274-8. PubMed ID: 440271
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia.
    Louridas G
    S Afr J Surg; 1991 Jun; 29(2):50-2. PubMed ID: 1882314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-onset heparin-induced thrombocytopenia.
    Smythe MA; Stephens JL; Mattson JC
    Ann Emerg Med; 2005 Apr; 45(4):417-9. PubMed ID: 15795722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-associated thrombocytopenia].
    Janssens M; Van Daele G; Matricali G; Hendrickx M; Eyskens E
    Acta Chir Belg; 1989; 89(2):73-6. PubMed ID: 2667275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia.
    Opatrny L; Warner MN
    Am J Hematol; 2004 Jul; 76(3):240-4. PubMed ID: 15224359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia. Diagnosis, natural history, and treatment options.
    Kelton JG; Warkentin TE
    Postgrad Med; 1998 Feb; 103(2):169-71, 175-8. PubMed ID: 9479314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin-induced thrombocytopenia reexposed to heparin.
    Cadroy Y; Amiral J; Raynaud H; Brunel P; Mazaleyrat A; Sauer M; Sié P
    Thromb Haemost; 1994 Nov; 72(5):783-4. PubMed ID: 7900087
    [No Abstract]   [Full Text] [Related]  

  • 14. [Summary of pathophysiology and diagnosis of patients with platelet abnormality].
    Wada H; Asakura H
    Rinsho Byori; 2009 May; 57(5):474-6. PubMed ID: 19522256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-Induced Thrombocytopenia.
    Frazer CA
    J Infus Nurs; 2017; 40(2):98-100. PubMed ID: 28248809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin induced thrombocytopenia causing life-threatening postoperative haemorrhage.
    Rice P; Dace S; McMullin MF; Clements WD
    Br J Clin Pract; 1996; 50(7):404-5. PubMed ID: 9015918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation, temporal relationship, and outcome in thirty-three patients with type 2 heparin-induced thrombocytopenia after cardiotomy.
    Wan C; Warner M; De Varennes B; Ergina P; Cecere R; Lachapelle K
    Ann Thorac Surg; 2006 Jul; 82(1):21-6. PubMed ID: 16798180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence.
    Ong SY; Chin YA; Than H; Tan CW; Yap ES; Wong WH; Ng HJ
    Ann Hematol; 2017 Mar; 96(3):525-527. PubMed ID: 27822611
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia.
    Chong BH; Chong JJ
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):547-59. PubMed ID: 15225114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?
    Zhou A; Winkler A; Emamifar A; Gartland B; Duncan A; Antun A; Arellano M; Tindol GA; Levy JH; Bornstein WA; Horowitz IR; Khoury HJ
    Chest; 2012 Nov; 142(5):1175-1178. PubMed ID: 22539642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.